Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Tuesday, March 3 2015 11:47am ET - U.S. Markets close in 4 hours and 13 minutes.
Industry Center
Industry Center > > Novartis Corporation Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Novartis Corporation Company Profile
Novartis Corporation has what the doctor ordered. As the US headquarters of Switzerland-based Novartis AG, the unit handles administration, sales, and marketing for a vast product line of prescription drugs, vaccines, consumer medicines, and veterinary products. Novartis Corporation also oversees the Novartis Institutes for Biomedical Research, which is headquartered in the US, and charged with the job of discovering new medicines to add to the company's ever-expanding pipeline. Novartis Corporation also headlines dozens of other US business units, including Novartis Pharmaceuticals Corporation (NPC) and the US locations of Novartis' Alcon ophthalmics and Sandoz generics businesses.
Headlines for Novartis Corporation
GSK and Novartis complete deals to reshape both drugmakers
- Mon 11:27 am ET
GSK completes transaction with Novartis
- Mon 11:31 am ET
Novartis treatment for vision loss meets goals in study
- Fri Feb 27
Novartis AG wins approval to buy GSK cancer drugs, with conditions
- Mon Feb 23
Pfizer, Novartis say meningitis vaccine scope too narrow
- Thu Feb 26
GSK completes three-part transaction with Novartis that will see it acquire vaccines business
- Mon 12:26 pm ET
Novartis blood cancer drug wins U.S. OK after setback
- Mon Feb 23
FDA approves Novartis drug for bone marrow cancer
- Mon Feb 23
GSK set to complete $20 billion Novartis asset swap next week
- Wed Feb 25
Novartis lung cancer drug gets EU recommendation
- Fri Feb 27
Contact Information
Address: 608 5th Ave.
New York, NY 10020
Phone:212-307-1122
Fax:212-246-0185
Key People
President; President, Novartis Pharmaceuticals: André (Andy) Wyss
Head, US Corporate Public Affairs: Jim Elkin
VP Communications: Brandi Robinson
Industry Information
Sector:
Industry:
Top Competitors
Merck & Co., Inc. (mrk)
Pfizer Inc. (pfe)
Sanofi (sny)
 


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?